Somatomedin: Difference between revisions

Latest revision as of 04:06, 13 February 2025

Somatomedin[edit]

Structure of Insulin-like Growth Factor 1 (IGF-1)

Somatomedin refers to a group of peptide hormones that are primarily involved in the regulation of growth and development in the body. The most well-known somatomedin is Insulin-like Growth Factor 1 (IGF-1), which plays a crucial role in mediating the effects of growth hormone (GH).

Function[edit]

Somatomedins, particularly IGF-1, are produced in response to stimulation by growth hormone. They are primarily synthesized in the liver, although other tissues can also produce them. Once released into the bloodstream, somatomedins bind to specific receptors on target cells, promoting cell growth, cell differentiation, and cell survival.

IGF-1, in particular, has a structure similar to insulin and can exert insulin-like effects in addition to its growth-promoting activities. It is involved in the growth of bone and muscle tissue, and it plays a role in metabolism by influencing the uptake of glucose and amino acids.

Mechanism of Action[edit]

Somatomedins exert their effects by binding to the IGF-1 receptor, a tyrosine kinase receptor found on the surface of many cell types. This binding activates intracellular signaling pathways, such as the PI3K-Akt pathway and the MAPK/ERK pathway, which lead to the biological effects associated with IGF-1.

Clinical Significance[edit]

Abnormal levels of somatomedins can lead to various medical conditions. For instance, excessive production of IGF-1 can result in acromegaly or gigantism, while insufficient levels can cause growth hormone deficiency and dwarfism.

IGF-1 levels are also studied in the context of aging, as they are believed to play a role in the aging process and the development of age-related diseases. Additionally, IGF-1 has been implicated in cancer biology, as it can promote the growth and survival of cancer cells.

Related Pages[edit]

@@ Line 1: / Line 1: @@
-'''Somatomedin''' refers to a group of proteins that are produced in the liver when stimulated by [[growth hormone]] (GH). They are also known as [[Insulin-like growth factors]] (IGFs) due to their structural similarity to insulin. The two most well-known types of somatomedin are [[Somatomedin C]] (also known as IGF-1) and [[Somatomedin A]] (also known as IGF-2).
+== Somatomedin ==
+[[File:2gf1.jpg|thumb|right|Structure of Insulin-like Growth Factor 1 (IGF-1)]]
+'''Somatomedin''' refers to a group of [[peptide hormones]] that are primarily involved in the regulation of [[growth]] and [[development]] in the body. The most well-known somatomedin is [[Insulin-like Growth Factor 1]] (IGF-1), which plays a crucial role in mediating the effects of [[growth hormone]] (GH).
 == Function ==
-Somatomedins have a variety of functions in the body. They are primarily involved in promoting growth and development, particularly during childhood and adolescence. They do this by stimulating the growth of bone and muscle, and by promoting cell division and differentiation. In addition to their role in growth, somatomedins also have metabolic effects. They can increase glucose uptake and utilization, and they can promote protein synthesis.
-== Clinical significance ==
+Somatomedins, particularly IGF-1, are produced in response to stimulation by growth hormone. They are primarily synthesized in the [[liver]], although other tissues can also produce them. Once released into the bloodstream, somatomedins bind to specific receptors on target cells, promoting [[cell growth]], [[cell differentiation]], and [[cell survival]].
-Abnormal levels of somatomedin can lead to a variety of health problems. High levels can lead to [[acromegaly]], a condition characterized by excessive growth of the hands, feet, and face. Low levels can lead to [[growth hormone deficiency]], which can result in short stature and delayed growth. Somatomedin levels can also be affected by malnutrition, liver disease, and certain genetic disorders.
-== Measurement ==
+IGF-1, in particular, has a structure similar to [[insulin]] and can exert insulin-like effects in addition to its growth-promoting activities. It is involved in the growth of [[bone]] and [[muscle]] tissue, and it plays a role in [[metabolism]] by influencing the uptake of [[glucose]] and [[amino acids]].
-Somatomedin levels can be measured in the blood using a variety of techniques. These include radioimmunoassay, enzyme-linked immunosorbent assay (ELISA), and mass spectrometry. These tests can be used to diagnose conditions related to growth hormone and to monitor the effectiveness of treatment.
+== Mechanism of Action ==
+Somatomedins exert their effects by binding to the [[IGF-1 receptor]], a [[tyrosine kinase receptor]] found on the surface of many cell types. This binding activates intracellular signaling pathways, such as the [[PI3K-Akt pathway]] and the [[MAPK/ERK pathway]], which lead to the biological effects associated with IGF-1.
+== Clinical Significance ==
+Abnormal levels of somatomedins can lead to various medical conditions. For instance, excessive production of IGF-1 can result in [[acromegaly]] or [[gigantism]], while insufficient levels can cause [[growth hormone deficiency]] and [[dwarfism]].
+IGF-1 levels are also studied in the context of [[aging]], as they are believed to play a role in the aging process and the development of age-related diseases. Additionally, IGF-1 has been implicated in [[cancer]] biology, as it can promote the growth and survival of cancer cells.
+== Related Pages ==
-== See also ==
 * [[Growth hormone]]
-* [[Insulin-like growth factor]]
+* [[Insulin-like Growth Factor 1]]
 * [[Acromegaly]]
-* [[Growth hormone deficiency]]
+* [[Dwarfism]]
+* [[Endocrinology]]
-[[Category:Proteins]]
 [[Category:Hormones]]
 [[Category:Endocrinology]]
-{{stub}}